PFBT
NBIX icon

Parkside Financial Bank & Trust’s Neurocrine Biosciences NBIX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7K Sell
119
-85
-42% -$11.3K ﹤0.01% 1410
2025
Q4 		$28.9K Buy
204
+42
+26% +$6.08K ﹤0.01% 1173
2025
Q3 		$22.7K Buy
162
+65
+67% +$8.81K ﹤0.01% 1199
2025
Q2 		$12.2K Buy
97
+38
+64% +$4.36K ﹤0.01% 1425
2025
Q1 		$6.53K Buy
59
+44
+293% +$5.57K ﹤0.01% 1559
2024
Q4 		$2.05K Buy
15
+13
+650% +$1.61K ﹤0.01% 1623
2024
Q3 		$231 Hold
2
– – ﹤0.01% 1986
2024
Q2 		$276 Hold
2
– – ﹤0.01% 1885
2024
Q1 		$276 Hold
2
– – ﹤0.01% 1867
2023
Q4 		$264 Sell
2
-3
-60% -$345 ﹤0.01% 1880
2023
Q3 		$563 Buy
+5
New +$527 ﹤0.01% 1904
2023
Q2 		– Sell
-11
Closed -$1.11K – 2073
2023
Q1 		$1.11K Hold
11
– – ﹤0.01% 1828
2022
Q4 		$1.31K Buy
+11
New +$1.29K ﹤0.01% 1792
2021
Q4 		– Sell
-15
Closed -$1K – 1880
2021
Q3 		$1K Buy
+15
New +$1.42K ﹤0.01% 1687
2019
Q1 		– Sell
-171
Closed -$12K – 1609
2018
Q4 		$12K Hold
171
– – ﹤0.01% 707
2018
Q3 		$21K Hold
171
– – 0.01% 596
2018
Q2 		$17K Hold
171
– – 0.01% 626
2018
Q1 		$14K Buy
171
+31
+22% +$2.62K 0.01% 650
2017
Q4 		$11K Buy
+140
New +$9.55K ﹤0.01% 714

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's NBIX Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Neurocrine Biosciences (NBIX) stake by 42% in Q1 2026, selling an estimated $11.3K and leaving 119 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

Parkside Financial Bank & Trust first reported a position in NBIX in Q4 2017 and has held it in 19 quarters since. The position peaked at $28.9K in Q4 2025. 695 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Parkside Financial Bank & Trust held 119 shares of Neurocrine Biosciences worth $15.7K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 85 Neurocrine Biosciences shares in Q1 2026, an estimated $11.3K.
  • Neurocrine Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1410 holding.
  • Parkside Financial Bank & Trust first reported a position in Neurocrine Biosciences in Q4 2017 and has held it in 19 quarters since.
  • Parkside Financial Bank & Trust's Neurocrine Biosciences position peaked at $28.9K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.